Up Next
Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Sign up now for inspiring and thought-provoking media delivered straight to your inbox.
Support Provided By
57:46
May 8, 2025 - PBS News Hour full episode
57:46
May 7, 2025 - PBS News Hour full episode
57:46
May 6, 2025 - PBS News Hour full episode
57:46
May 5, 2025 - PBS News Hour full episode
26:45
May 4, 2025 - PBS News Weekend full episode
26:44
May 3, 2025 - PBS News Weekend full episode
56:45
May 2, 2025 - PBS News Hour full episode
56:42
May 1, 2025 - PBS News Hour full episode
56:44
April 30, 2025 - PBS News Hour full episode
56:45
April 29, 2025 - PBS News Hour full episode
56:45
April 28, 2025 - PBS News Hour full episode
26:45
April 27, 2025 - PBS News Weekend full episode